Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
The Lancet HIV.
2023.
10
(6):
e363-e374.
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV
Scientific Reports.
2023.
13
(1):
Depression and Anxiety in Youth and Young Adults Living with HIV: Frequency and Associated Factors in Thai Setting
Journal of the International Association of Providers of AIDS Care.
2022.
21
A Risk Prediction Model and Risk Score of SARS-CoV-2 Infection Following Healthcare-Related Exposure
Tropical Medicine and Infectious Disease.
2022.
7
(9):
Occupational Post-exposure Prophylaxis after Blood and Body Fluids Exposure among Healthcare Workers in Siriraj Hospital
Siriraj Medical Journal.
2022.
74
(11):
787-791.
Attitudes towards, knowledge about, and confidence to prescribe antiretroviral pre-exposure prophylaxis among healthcare providers in Thailand
Medicine (United States).
2021.
100
(49):
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial
The Lancet HIV.
2020.
7
(5):
e322-e331.
Association between the appropriate antimicrobial therapy and clinical outcomes in patients with sepsis
Thai Journal of Pharmaceutical Sciences.
2019.
43
(2):
110-118.
Attitudes, confidence and knowledge towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among health-care providers in Thailand
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY.
2019.
22
90-90.
